CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project introduces a novel ultrasound contrast agent designed for long-term imaging applications in medical treatments. The CoNQUeST platform aims to improve tracking of cellular therapies by providing stable, multimodal imaging capabilities without the limitations of current agents.
The success of modern medical treatments such as cellular therapy and targeted treatments requires appropriate tools for in vivo monitoring.
Imaging modalities, such as magnetic resonance imaging (MRI), single photon emission computed tomography (SPECT) and positron emission tomography (PET) are key candidates due to their noninvasive nature.
However, these imaging techniques are extremely expensive and can involve radiation, both of which hinder their longitudinal and repetitive use.Ultrasound…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
